Commentary by Dr. Pavel Martinez-Dominguez.
Commentary by Dr. Nicolas Palaskas & Dr. Keila Ostos-Mendoza.
Commentary by Yi Li, MA.
Commentary by Dr. Vivek Narayan.
Commentary by Dr. Eli Muchtar.
Commentary by Dr. Bonnie Ky.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Alston Chiu.
Commentary by Dr. Kohei Ishibashi.
Commentary by Dr. Yoshihiro Miyamoto.
Commentary by Dr. Taku Kato.
Commentary by Dr. Sheryl Chow.
Mirza Umair Khalid, MD, social media editor of JACC: Cardiovascular Interventions, and Niccolò Ciardetti, MD discuss a recently published study examining use of Drug Coated Balloons for CTO PCI in the large ERCTO registry.
Abdullah Al-Abcha, MD, social media editor of JACC: Cardiovascular Interventions, and Aloke Finn, MD discuss the comparison of vascular injury from intravascular lithotripsy, cutting, or ultra-high-pressure balloons during coronary calcium modification.